First Episealer® Talus surgery planned in Estonia
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the ankle implant Episealer® Talus in Estonia has been scheduled. “It is pleasing that more and more patients globally can be helped by the Episealer® technology, with Estonia being the most recent addition on our global strategy”, says Pål Ryfors, CEO Episurf Medical.